Based on these findings, high LY6H expression was found to be significantly associated with a poorer prognosis in patients with LUAD, LIHC, KIRP, CHOL, CESC, BRCA, COAD, GBM and OV. The gene discussed is LY6H; the disease is glioblastoma.